0001104659-24-001373.txt : 20240104 0001104659-24-001373.hdr.sgml : 20240104 20240104162450 ACCESSION NUMBER: 0001104659-24-001373 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240103 FILED AS OF DATE: 20240104 DATE AS OF CHANGE: 20240104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LUCI DAVID P CENTRAL INDEX KEY: 0001271123 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40536 FILM NUMBER: 24512277 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Acurx Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001736243 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 259 LIBERTY AVENUE CITY: STATEN ISLAND STATE: NY ZIP: 10305 BUSINESS PHONE: 917-533-1469 MAIL ADDRESS: STREET 1: 259 LIBERTY AVENUE CITY: STATEN ISLAND STATE: NY ZIP: 10305 FORMER COMPANY: FORMER CONFORMED NAME: Acurx Pharmaceuticals, LLC DATE OF NAME CHANGE: 20180402 4 1 tm242052-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-01-03 0 0001736243 Acurx Pharmaceuticals, Inc. ACXP 0001271123 LUCI DAVID P C/O ACURX PHARMACEUTICALS, INC., 259 LIBERTY AVENUE STATEN ISLAND NY 10305 1 1 1 0 President and CEO 0 Common Stock 2024-01-03 4 M 0 19737 3.55 A 1048197 D Common Stock 15083 I By spouse Common Stock 35000 I By child Warrants for Common Stock 3.55 2024-01-03 4 M 0 19737 0 D 2023-01-27 2024-01-27 Common Stock 19737 0 D /s/ David P. Luci 2024-01-04